Section analysis by Tatiana Kantor, CFPC, CPB, Billing Department, WCH
Editorial note: This article reflects ACC/SCAI published guidance, CMS payment data, and summer 2026 cardiology practice management analysis. OBL and ASC reimbursement rates vary by payer and geography. ACC/SCAI guidance cited reflects documents current as of mid-2026; readers should verify current versions directly with ACC and SCAI. This article is for informational and educational purposes and does not constitute clinical, legal, financial, or compliance advice.
The summer of 2026 is the moment when the office-based laboratory and ambulatory surgical center migration in interventional cardiology has crossed from emerging trend to operational reality for a majority of high-volume practices. The combination of a 2026 MPFS non-facility payment environment that has produced approximately 5% payment gains in non-facility procedure categories, concurrent cuts to facility-based reimbursement that are eroding the economics of hospital outpatient cardiac procedure delivery, and updated ACC/SCAI guidance that has clarified the clinical appropriateness standards for OBL and ASC-based cardiovascular procedures — has created a convergence that practices across the country are responding to with investment decisions that will define their competitive position for the next decade.
The Payment Shift: Non-Facility Gains and Facility Cuts
The 2026 MPFS Final Rule has produced a site-of-service payment differential in interventional cardiology that is among the most pronounced in any specialty. Non-facility settings — office-based laboratories and freestanding ASCs — are showing payment gains of approximately 5% for key interventional cardiology procedure categories relative to prior-year non-facility rates, while hospital outpatient department reimbursement for comparable procedures faces OPPS rate adjustments and site-neutral payment policy pressure that is reducing facility-based physician payment. The combined effect — non-facility up, facility down — has sharpened the financial case for OBL and ASC-based procedure delivery in ways that summer 2026 financial modeling is documenting with unusual clarity.
The procedure categories most affected by this differential in interventional cardiology include peripheral vascular interventions — angioplasty, stenting, atherectomy — performed in OBL settings; diagnostic cardiac catheterization where the non-facility billing pathway is applicable; electrophysiology procedures including ablations being evaluated for ASC migration; and select structural heart procedures where the clinical and regulatory pathway for ASC-based performance is being actively developed. Each of these categories has a different site-of-service migration profile in terms of patient selection requirements, equipment needs, and payer coverage, but all are being examined with fresh financial urgency in the summer 2026 practice management environment.
ACC/SCAI Updates: The Clinical Appropriateness Framework
The financial case for OBL and ASC-based cardiovascular procedures is compelling under the 2026 rate structure, but the clinical framework for appropriate patient selection in non-hospital settings is equally important — both for patient safety and for the regulatory and payer scrutiny that OBL-based cardiovascular procedures continue to attract following the May 2026 OIG report on peripheral vascular billing documented in the radiology section of this journal.
ACC and SCAI have been publishing updated guidance in 2025–2026 that addresses the clinical appropriateness standards for OBL and ASC-based cardiovascular procedures with increased specificity. The guidance framework covers patient selection criteria for non-hospital cardiovascular procedure performance — cardiac risk stratification, renal function thresholds, contrast allergy protocols, anticoagulation management, and the clinical scenarios that require hospital-based rather than OBL or ASC setting. It addresses emergency preparedness requirements for OBL and ASC cardiovascular programs, including resuscitation equipment, emergency transfer protocols, and staff training standards. And it addresses the quality metrics and outcomes reporting that ACC and SCAI recommend for programs performing cardiovascular procedures outside hospital settings — volume thresholds, complication rate monitoring, and case review processes.
For practices building or expanding OBL and ASC cardiovascular programs, alignment with current ACC/SCAI guidance is both clinically appropriate and strategically important. The OIG and CMS oversight of OBL-based cardiovascular procedures that the peripheral vascular billing enforcement context has made visible in 2026 is not limited to billing pattern analysis — it extends to whether programs performing these procedures are meeting the clinical standards that their professional societies have articulated. Programs that can document alignment with ACC/SCAI patient selection and quality standards are in a substantially stronger position in any audit or enforcement interaction than programs that cannot.
The Electrophysiology Migration: Ablations Moving to ASC
Among the most significant procedural migrations discussed in summer 2026 cardiology practice management is the movement of catheter ablation procedures — historically performed exclusively in hospital electrophysiology laboratories — into ASC settings. The clinical and regulatory requirements for ASC-based ablation are substantial: appropriate patient selection excluding high-risk anatomical and comorbidity presentations, full hemodynamic monitoring capability, advanced cardiac life support readiness, and appropriate post-procedure monitoring infrastructure. But for appropriately selected patients, the ASC-based ablation model is clinically viable — and the payment differential under the 2026 rate structure makes it financially compelling for high-volume EP programs with the infrastructure to support it.
SCAI and the Heart Rhythm Society have been developing quality standards for ASC-based ablation programs that are being incorporated into the summer 2026 guidance updates. Practices considering ablation ASC migration should engage with these standards early in the program development process — building clinical protocols around the appropriate guidance framework from the outset is substantially more efficient than retrofitting protocols onto an already-operational program.
The PCI Question: Where ASC-Based Percutaneous Coronary Intervention Stands
Percutaneous coronary intervention in ASC settings remains the most actively debated migration question in interventional cardiology. PCI carries higher acute complication risk than most other cardiovascular procedures, and the management of serious complications — coronary perforation, tamponade, hemodynamic instability — requires surgical backup capability and intensive care infrastructure that most ASC settings cannot provide. The ACC/SCAI position on ASC-based PCI has been cautious — supporting its feasibility in very carefully selected low-risk elective cases with robust emergency protocols, while emphasizing that the vast majority of PCI volume remains appropriately hospital-based.
The summer 2026 discussion has not dramatically changed that clinical positioning, but it has increased the scrutiny on the financial and operational modeling for low-risk elective PCI in ASC settings as the payment differential makes the case more compelling from a practice economics perspective. Practices should evaluate the current ACC/SCAI position documents directly and engage with their state health department regulatory requirements — which vary significantly — before making ASC-based PCI program investments.
Building a Defensible OBL/ASC Cardiovascular Program
The practices that are building sustainable OBL and ASC cardiovascular programs in 2026 are doing so with a compliance and quality infrastructure that matches the clinical ambition of the program — not just the financial opportunity. The OIG attention to OBL-based cardiovascular billing documented earlier in this journal is the context within which every new OBL cardiovascular program is being launched this year. The practices that will navigate that environment successfully are those with documented patient selection criteria, robust medical necessity documentation for every case, outcomes monitoring that meets ACC/SCAI standards, and billing practices that are auditable against current coverage policies.
The financial case for OBL and ASC-based cardiovascular procedure delivery in 2026 is among the strongest it has ever been. The compliance and quality requirements for operating in that environment are equally clear. The practices that are succeeding are treating both dimensions as equally non-negotiable — not as a financial opportunity to be captured with compliance managed as an afterthought.
| ★ The summer 2026 The OBL and ASC migration in interventional cardiology has crossed from trend to operational imperative for practices positioned to participate. The 2026 payment differential, the ACC/SCAI clinical framework, and the enforcement environment established by the OIG’s peripheral vascular billing focus are all visible simultaneously — and they all point toward the same conclusion: programs that are built on sound clinical patient selection, compliant billing practices, and ACC/SCAI-aligned quality standards will capture the financial opportunity the non-facility payment environment is providing. Programs that are built primarily on the financial opportunity, without the clinical and compliance infrastructure, are building in the wrong order. |
Sources:
- CMS Physician Fee Schedule Final Rule CY 2026: Non-Facility Payment Values for Cardiovascular Procedures. cms.gov/medicare/physician-fee-schedule
- ACC/SCAI. “Quality Standards for Office-Based and ASC Cardiovascular Procedures: 2025–2026 Update.” acc.org; scai.org
- Society for Cardiovascular Angiography and Interventions. “ASC-Based Ablation: Clinical Standards and Program Development Guidance.” SCAI, 2026. scai.org
- Heart Rhythm Society. “ASC-Based Electrophysiology Procedures: Quality and Safety Framework.” hrsonline.org, 2025–2026.
- OIG Report OEI-01-24-00250. “Medicare Part B Billing for Office-Based Peripheral Vascular Procedures.” oig.hhs.gov, May 2026.
Discover more from Doctor Trusted
Subscribe to get the latest posts sent to your email.
